吡柔比星的局部毒性：一种蒽并吡唑类药物，具有与阿霉素相似的刺激和发泡特性。 - Suppr | 超能文献

Local toxicity of piroxantrone: an anthrapyrazole with irritant and vesicant properties similar to those of doxorubicin.

作者信息

Clarke B V, Harwood K V, Donehower R

出版信息

J Natl Cancer Inst. 1989 Sep 6;81(17):1331-2. doi: 10.1093/jnci/81.17.1331.

DOI:10.1093/jnci/81.17.1331

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Local toxicity of piroxantrone: an anthrapyrazole with irritant and vesicant properties similar to those of doxorubicin.吡柔比星的局部毒性：一种蒽并吡唑类药物，具有与阿霉素相似的刺激和发泡特性。

J Natl Cancer Inst. 1989 Sep 6;81(17):1331-2. doi: 10.1093/jnci/81.17.1331.

2

Comparison of the chronic toxicity of piroxantrone, losoxantrone and doxorubicin in spontaneously hypertensive rats.吡柔比星、洛索蒽醌和阿霉素对自发性高血压大鼠的慢性毒性比较。

Toxicology. 1998 Jun 26;128(1):35-52. doi: 10.1016/s0300-483x(98)00049-3.

3

Preclinical pharmacology of the anthrapyrazole analog oxantrazole (NSC-349174, piroxantrone).蒽吡唑类似物奥沙蒽酮（NSC-349174，吡罗蒽醌）的临床前药理学

Cancer Chemother Pharmacol. 1989;23(4):213-8. doi: 10.1007/BF00451644.

4

Phase II trial of piroxantrone for advanced or metastatic soft tissue sarcomas. A Southwest Oncology Group study.吡柔比星治疗晚期或转移性软组织肉瘤的II期试验。一项西南肿瘤学组的研究。

Invest New Drugs. 1993 Nov;11(4):337-41. doi: 10.1007/BF00874435.

5

Phase I study of high-dose piroxantrone with granulocyte colony-stimulating factor.

J Clin Oncol. 1993 Sep;11(9):1795-803. doi: 10.1200/JCO.1993.11.9.1795.

6

A phase II trial of piroxantrone in advanced ovarian carcinoma after failure of platinum-based chemotherapy: Southwest Oncology Group Study 8904.

Gynecol Oncol. 1995 Jun;57(3):407-11. doi: 10.1006/gyno.1995.1163.

7

Pharmacokinetics, cerebrospinal fluid penetration, and metabolism of piroxantrone in the rhesus monkey.

Invest New Drugs. 1993 Nov;11(4):255-61. doi: 10.1007/BF00874424.

8

Pharmacokinetics of piroxantrone in a phase I trial of piroxantrone and granulocyte-colony stimulating factor.

Cancer Res. 1993 Jun 1;53(11):2587-90.

9

Phase I study and pharmacodynamics of piroxantrone (NSC 349174), a new anthrapyrazole.新型蒽吡唑类药物匹罗昔酮（NSC 349174）的I期研究及药效学

Cancer Res. 1990 Jun 1;50(11):3284-8.

10

A theoretical study of the intercalative binding of the anti-tumour drug anthrapyrazole to double-stranded oligonucleotides.抗肿瘤药物蒽吡唑与双链寡核苷酸嵌入结合的理论研究

Anticancer Drug Des. 1987 Aug;2(1):79-84.

引用本文的文献

1

Phase II trial of piroxantrone for advanced or metastatic soft tissue sarcomas. A Southwest Oncology Group study.吡柔比星治疗晚期或转移性软组织肉瘤的II期试验。一项西南肿瘤学组的研究。

Invest New Drugs. 1993 Nov;11(4):337-41. doi: 10.1007/BF00874435.

2

Phase II evaluation of piroxantrone in renal cell carcinoma. A Southwest Oncology Group Study.吡柔比星用于肾细胞癌的II期评估。西南肿瘤协作组研究。

Invest New Drugs. 1992 Jul;10(2):129-32. doi: 10.1007/BF00873131.